← back to search

Jian Xu

Xinjiang Agricultural University · CN
Area of research
Rheumatology · Cognitive Neuroscience
Research interest
Research interests include Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies, Functional Brain Connectivity Studies, and Spondyloarthritis Studies and Treatments.
h-index
29
citations
4,104
works
159
NIH funding
primary concept
Medicine
email

Recent publications

Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort study
Rheumatology and Immunology Research 2025cited by 4position: middledoi
Dynamic changes in hemispheric lateralization in major depressive disorder correlate with neurotransmitter and genetic profiles: a DIRECT consortium study
Translational Psychiatry 2025cited by 3position: lastdoi
Chinese Registry of Rheumatoid Arthritis (CREDIT) VI: Temporal Trends in Patients With Early Rheumatoid Arthritis and Moderate‐To‐Severe Disease Activity ‐ A Multicenter Cohort Study of Treatment Strategies and Outcomes
International Journal of Rheumatic Diseases 2025cited by 2position: middledoi
OP0299 GENAKUMAB REDUCES THE RISK OF ACUTE GOUT FLARES DURING INITIATION OF URATE-LOWERING THERAPY: A PHASE 2, RANDOMIZED, OPEN-LABEL, MULTI-CENTER, ACTIVE-CONTROLLED CLINICAL TRIAL
Annals of the Rheumatic Diseases 2025cited by 1position: middledoi
Role of combination immunotherapy in restoring brain synergistic functional connectivity in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations
Lupus Science & Medicine 2025cited by 1position: lastdoi
First identification of camel Contagious Ecthyma Virus in camels from Altay, Xinjiang, China
New Microbes and New Infections 2025cited by 0position: middledoi
Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study
Arthritis Research & Therapy 2024cited by 6position: middledoi
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study
RMD Open 2023cited by 22position: middledoi
Hyperglobulinemia predicts increased risk of mortality in primary Sjögren’s syndrome: Based on a Chinese multicentre registry
Modern Rheumatology 2023cited by 12position: middledoi
Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus
RMD Open 2023cited by 10position: middledoi
Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
Arthritis Research & Therapy 2023cited by 9position: middledoi
Chinese Registry of Psoriatic Arthritis (<scp>CREPAR</scp>): I. Clinical characteristics of Chinese patients with psoriatic arthritis
International Journal of Rheumatic Diseases 2023cited by 6position: middledoi
Enthesitis in patients with psoriatic arthritis: A nationwide data from the Chinese Registry of Psoriatic Arthritis (CREPAR)
Chinese Medical Journal 2023cited by 5position: middledoi
Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
Chinese Medical Journal 2022cited by 21position: middledoi
Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients
Chinese Medical Journal 2022cited by 16position: middledoi
Renal tubular acidosis and associated factors in patients with primary Sjögren’s syndrome: a registry-based study
Clinical Rheumatology 2022cited by 10position: middledoi
Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study
Arthritis Research & Therapy 2022cited by 5position: middledoi
Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus
Frontiers in Medicine 2022cited by 3position: middledoi
Advances and challenges in the treatment of esophageal cancer
Acta Pharmaceutica Sinica B 2021cited by 297position: middledoi
Predicting the Risk of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: A Chinese Systemic Lupus Erythematosus Treatment and Research Group Cohort Study
Arthritis & Rheumatology 2021cited by 40position: middledoi
Impaired robust interhemispheric function integration of depressive brain from REST‐meta‐MDD database in China
Bipolar Disorders 2021cited by 20position: middledoi
Association between global visual scanning and cognitive function in schizophrenia
Asian Journal of Psychiatry 2021cited by 9position: middledoi
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study
Clinical Rheumatology 2021cited by 4position: middledoi
A neuroimaging biomarker for striatal dysfunction in schizophrenia
Nature Medicine 2020cited by 253position: middledoi
Clinical features and current treatments of adult-onset Still's disease: a multicentre survey of 517 patients in China.
PubMed 2020cited by 36position: middle
Comparison of Clinical Features in HLA-B27 Positive and Negative Patients With Axial Spondyloarthritis: Results From a Cohort of 4,131 Patients
Frontiers in Medicine 2020cited by 30position: middledoi
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial
BioDrugs 2020cited by 29position: middledoi
Treatment satisfaction with rheumatoid arthritis in patients with different disease severity and financial burden: A subgroup analysis of a nationwide survey in China
Chinese Medical Journal 2020cited by 18position: middledoi
Association between comorbidities and extraglandular manifestations in primary Sjögren’s syndrome: a multicenter cross-sectional study
Clinical Rheumatology 2020cited by 17position: middledoi
&lt;p&gt;Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China&lt;/p&gt;
Patient Preference and Adherence 2020cited by 13position: middledoi

Grants

CAREER: Image critical dental diseases that current dental X-ray/CT fails to detect, without ionizing radiation
NSF2046929$500,0002021–2027PIRePORTER
CAREER: Two-Photon Pumped Lasing Using Semiconductor Nanostructures by Design
NSF0846818$400,0002009–2014PIRePORTER
First International Symposium on Semiconductor and Plasmonics-Active Nanostructures for Photonic Devices and Systems (Electronics and Photonics); Vienna, Austria; October 4-9, 2009
NSF0939548$20,4702009–2009PIRePORTER
GOALI: Enhanced Nonradiative Energy Coupling between Quantum Dot Phosphors and InGaN Emitters - Towards High-Efficiency White LEDs
NSF0824186$348,0002008–2012PIRePORTER
GOALI: Mist-Deposition Based Manufacturing of Matrix Displays from Solution-Processed Semiconductor Quantum Dots
NSF0729263$337,7622007–2011PIRePORTER

Frequent collaborators

Xinwang Duan · Nanchang University17 papers (2020–2025)Mengtao Li · Ministry of Education of the People's Republic of China14 papers (2020–2024)Lijun Wu · Fudan University12 papers (2020–2024)Xiaofeng Zeng · Academy of Medical Sciences12 papers (2020–2025)Xinping Tian · Academy of Medical Sciences11 papers (2020–2025)Jiuliang Zhao · Ministry of Education of the People's Republic of China11 papers (2020–2025)Xiaomei Leng · Ministry of Education of the People's Republic of China9 papers (2021–2025) · 7 papers (2020–2023)Min Yang · Anhui Medical University7 papers (2020–2024)Cheng Zhao · Nantong University6 papers (2020–2023)Hongbin Li · Ministry of Education of the People's Republic of China5 papers (2020–2023)Qian Wang · Shanghai University5 papers (2020–2023)Xiaofeng Zeng · Ministry of Education of the People's Republic of China5 papers (2020–2024) · 5 papers (2020–2023)Nan Jiang · Nanchang University5 papers (2020–2025)Yan Zhao · Ministry of Education of the People's Republic of China4 papers (2020–2024)Zhenyu Jiang · China Pharmaceutical University4 papers (2020–2025)Feng Zhan · Jiangsu University4 papers (2021–2023) · 4 papers (2020–2025)Dong Xu · Shandong University4 papers (2020–2023)